Background: Little is known about prevalence of drug resistance among HIV-infected
Ugandans, a setting with over 15 years of public sector access to antiretroviral therapy (ART) …

To investigate the prevalence of transmitted drug resistance (TDR) among individuals with
recent HIV-1 infection between February 2004 and January 2010 in a rural clinical cohort …

Background We assessed the prevalence of acquired HIV drug resistance (HIVDR) and
associated factors among patients receiving first-line antiretroviral therapy (ART) in Rwanda …

Background There are few data on the epidemiology of primary HIV-1 drug resistance after
the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the …

Objective We describe phenotypic drug resistance, response to therapy, and genotypic
mutations among HIV-infected patients in Uganda taking antiretroviral medications for≥ 90 …

We analyzed antiretroviral drug susceptibility in HIV-infected adults failing first-and second-
line antiretroviral treatment (ART) in Rakai, Uganda. Samples obtained from participants at …

Background: We studied virological outcome and drug resistance in patients on antiretroviral
therapy (ART) in health care centers in the Democratic Republic of Congo and looked for the …

Background. Emergence of human immunodeficiency virus type 1 (HIV-1) drug resistance
may limit the benefits of antiretroviral therapy in resource-limited settings. The prevalence of …

Few reports have examined the impact of HIV-1 transmitted drug resistance (TDR) in
resource-limited settings where there are fewer regimen choices and limited pretherapy …

Introduction: Antiretroviral therapy plays a major role in reducing the impact of Human
Immunodeficiency Virus/Acquired Immune Disease Syndrome, especially in resource …